Antinuclear Antibody Determination: The Present State of Diagnostic and Clinical Relevance

References

• Friou G. J. Clinical application of lupus serum nucleo-protein reaction using fluorescent antibody technique (abstract). J Clin Invest 1957; 36: 890
   Web of Science ®Google Scholar
• Holman H. R., Kunkel H. G. Affinity between the lupus erythematosus serum factor and cell nuclei and nucleo protein. Science 1957; 126: 162
   PubMed Web of Science ®Google Scholar
• Holborow E. J., Weir D. M., Johnson G. D. A serum factor in lupus erythematosus with affinity for tissue nuclei. Br Med J 1957; 2: 732
   PubMed Web of Science ®Google Scholar
• Hurd E. R., Chubick A., Jasin H. E., Ziff M. Increased Clq binding immune complexes in Felty's syndrome. Arthritis Rheum 1979; 22: 697
   PubMedGoogle Scholar
• Aitcheson C. T., Peebles C., Joslin F., Tan E. M. Characteristics of antinuclear antibodies in rheumatoid arthritis. Arthritis Rheum 1980; 23: 528
   PubMedGoogle Scholar
• Bucknall R. C., Davis P., Bacon P. A., Verrier-Jones J. Neutropenia in rheumatoid arthritis: studies on possible contributing factors. Ann Rheum Dis 1982; 41: 242
   PubMedGoogle Scholar
• Quismorio F. P., Beardmore T., Kaufman R. L., Morgan E. S. IgG rheumatoid factors and anti-nuclear antibodies in rheumatoid arthritis. Clin Exp Immunol 1983; 52: 331
   Google Scholar
• Alspaugh M. A., Shoji H., Nonoyauma M. A search for rheumatoid arthritis associated nuclear antigens and Epstein-Barr virus specific antigens or genomes in tissues and cells from patients with rheumatoid arthritis. Arthritis Rheum 1983; 26: 712
   PubMedGoogle Scholar
• Bendixen G., Hadidi T., Manthorpe R., Permin H., Struckmann J., Wiik A., Zaghloul M. Antibodies against nuclear components in schistosomiasis. Allergy 1984; 39: 107
   PubMedGoogle Scholar
• Moutsopoulos H. M., Klippel J. H., Pavlidis N., Wolf R. O., Sweet J. B., Steinberg A. D., Chu F. C., Tarpley T. M. Correlative histologic and serologic findings of Sicca syndrome in patients with systemic lupus erythematosus. Arthritis Rheum 1980; 23: 36
   PubMed Web of Science ®Google Scholar
• Alspaugh M. A., Buchanan W. W., Whaley K. Precipitating antibodies to cellular antigens in Sjögren's syndrome, rheumatoid arthritis and other organ and non-organ specific autoimmune diseases. Ann Rheum Dis 1978; 37: 244
   PubMedGoogle Scholar
• Martinez-Lavin M., Vaughan J. H., Tan E. M. Autoantibodies and the spectrum of Sjögren's syndrome. Ann Int Med 1979; 91: 185
   PubMed Web of Science ®Google Scholar
• Miyachi K., Niabo M., Maeno Y., Suzuki S., Mamamoto T., Sugiura M., Kasahara M., Torikai K., Umeda H. Sialographic study in patients with and without antibodies to Sjögren's Syndrome A (Ro). J Rheumatol 1983; 10: 389
   Google Scholar
• Alspaugh M. A., Miller J. J. A study of specificities of nuclear antibodies in juvenile rheumatoid arthritis. J Pediatrics 1977; 90: 391
   PubMed Web of Science ®Google Scholar
• Gioud M., Aitkaci M., Monier J. C. Histone antibodies in systemic lupus erythematosus. A possible diagnostic tool. Arthritis Rheum 1982; 25: 407
   PubMedGoogle Scholar
• Rubin R. L., Josh F. G., Tan E. M. Specificity of anti-histone antibodies in systemic lupus erythematosus. Arthritis Rheum 1982; 25: 779
   PubMedGoogle Scholar
• Fritzler M. J., Kinsella T. D. The CREST-syndrome: a distinct serologic entity with anticentromere antibodies. Am J Med 1980; 69: 520
   PubMed Web of Science ®Google Scholar
• Notman D. D., Kurata N., Tan E. M. Profiles of antinuclear antibodies in systemic lupus erythematosus. Ann Rheum Dis 1975; 83: 464
   Google Scholar
• Masi A. T., Rodnan G. P. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Bull Rheum Dis 1981; 31: 1
   PubMedGoogle Scholar
• McCarty G. A., Rice J. R., Bembe M. L., Pisetsky D. S. Independent expression of autoantibodies in systemic lupus erythematosus. J Rheum 1982; 9: 691
   PubMed Web of Science ®Google Scholar
• Hughes G. R.V., Rynes R. I., Gharavi A., Ryan P. F. J., Sewell J., Mansilla R. The heterogeneity of serologic findings and predisposing host factors in drug-induced lupus erythematosus. Arthritis Rheum 1981; 24: 1070
   PubMedGoogle Scholar
• Fritzler M. J., Tan E. M. Antibodies to histones in drug-induced and idiopathic lupus erythematosus. J Clin Invest 1978; 62: 560
   PubMed Web of Science ®Google Scholar
• Batchelor J. R., Welsh K. F., Tinoco R. M., Dollery C. T., Hughes G. R. V., Bernstein R., Ryan P., Naish P. F., Aber G. M., Bing R. F., Russell G. T. Hydralazine-induced systemic lupus erythematosus: influence of HLA-Dr and sex on suscep. Lancet 1980; 1107
   PubMedGoogle Scholar
• Woosley R. L., Drayer D. E., Reidenberg M. M. Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome. N Engl J Med 1978; 298: 1157
   PubMed Web of Science ®Google Scholar
• Lahita R., Kluger J., Drayer D. E., Kotller D., Reidenberg M. M. Antibodies to nuclear antigen in patients treated with procainamide or acetylprocainamide. N Engl J Med 1979; 301: 1382
   PubMed Web of Science ®Google Scholar
• Klajman A., Kafri B., Shohat T., Drucker I., Moalem T., Jaretzky A. The prevalence of antibodies to histones induced by procainamide in old people, in cancer patients and in rheumatoid-like disease. Clin Immunol Immunopathol 1983; 27: 1
   PubMedGoogle Scholar
• Tan E. M., Portanova J. P. The role of histones as nuclear autoantigens in drug-related lupus erythematosus. Arthritis Rheum 1981; 24: 1064
   PubMedGoogle Scholar
• Cipoletti I., Buckingham R. B., LeonBarnes E., Peel R. L., Mahmood K., Cignetti F. E., Pierce J. M., Rabin B. S., Rodnan G. P. Sjögren's syndrome in progressive systemic sclerosis. Am Intern Med 1977; 87: 535
   Google Scholar
• Grennan D. M., Sloane D., Behan A., Carson W. D. Clinical significance of antibodies to native DNA as measured by a DNA binding technique in patients with articular features of rheumatoid arthritis. Ann Rheum Dis 1977; 36: 30
   PubMedGoogle Scholar
• Sarai T., Miyawaki S., Kurata N., Ofuji T. Characteristics of antibody to denatured DNA in sera of patients with SLE and other rheumatoid diseases. Clin Immunol Immunopathol 1980; 16: 474
   PubMedGoogle Scholar
• Tan E. M., Rodnan G. P., Garcia J., Moroi Y., Fritzler M. J., Peebles C. Diversity of antinuclear antibodies in progressive systemic sclerosis. Arthritis Rheum 1980; 23: 617
   PubMed Web of Science ®Google Scholar
• Baron M., Feiglin D., Hyland R., Urowitz M. B., Shiff B. Gallium lung scans in P. S. S. Arthritis Rheum 1983; 26: 969
   PubMedGoogle Scholar
• Wolfe J. F., Adelstein E., Sharp G. C. Antinuclear antibody with distinct specificity for polymyositis. J Clin Invest 1977; 59: 176
   PubMed Web of Science ®Google Scholar
• Nishikai M., Reichlin M. Heterogeneity of precipitating antibody systems in polymyositis and dermatomyositis. Characterization of the Jo-1 antibody system. Arthritis Rheum 1980; 23: 881
   PubMed Web of Science ®Google Scholar
• Yoshida S., Akizuki M., Mimori T., Yamagota H., Inada S., Homma M. The precipitating antibody to an acidic nuclear protein antigen, the Jo-I, in connective tissue diseases. Arthritis Rheum 1983; 26: 604
   PubMed Web of Science ®Google Scholar
• Koffler D., Carr R. I., Agnello V., Fiezi T., Kunkel H. G. Antibodies to polynucleotides: distribution in human serum. Science 1969; 166: 1648
   PubMedGoogle Scholar
• Kredich N. M., Skyler J. S., Foote L. J. Antibodies to native DNA in SLE. Arch Intern Med 1973; 131: 639
   PubMedGoogle Scholar
• Karsh J., Halbet S. P., Anken M., Klima E., Steinberg A. D. Anti-DNA, anti-deoxyribonu-cleoprotein and RF measured by ELISA in patients with SLE, Sjögren's syndrome and RA. Int Arch Allergy Appl Immunol 1982; 68: 60
   PubMedGoogle Scholar
• Breshnihan B., Grigor R., Hughes G. R. V. Prospective analysis of antiribonucleoprotein antibodies in SLE. Ann Rheum Dis 1977; 36: 557
   PubMedGoogle Scholar
• Nishikai M., Reichlin M. Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo-l antibody system. Arthritis Rheum 1980; 25: 881
   Google Scholar
• Amett F. C., Hirsch T. J., Bias W. B., Nishikai M., Reichlin M. The Jo-l antibody system in myositis: relationships to clinical features and HLA. J Rheumatol 1981; 8: 925
   PubMedGoogle Scholar
• Manthorp R., Bendixen G. Anti-DNA antibody determination in SLE. Predictive value as compared with the LE-cell test. Scand J Rheumatol 1978; 7: 247
   PubMedGoogle Scholar
• Cohen A. S., Reynold W. F., Franklin E. G., Kulka J. P., Ropes M. W., Shulman L. E., Wallace S. L. Preliminary criteria for the classification of SLE. Bull Rheum Dis 1971; 21: 643
   Google Scholar
• Swaak A. J. G., Groenwold J., Aarden L. A., Feltkamp T. E. W. Detection of anti-dsDNA as diagnostic tool. Ann Rheum Dis 1980; 40: 45
   Google Scholar
• Swaak A. J. G., Smeenk R. Anti-dsDNA as diagnostic tool. A prospective study of 441 non-SLE patients with anti-dsDNA in the circulation. Ann Rheum Dis, in press
   Google Scholar
• Sharp G. C. Mixed connective tissue disease. Current concepts. Arthritis Rheum 1978; 21: 181
   Google Scholar
• Jonsson J. Symptomatology and diagnosis in connective tissue disease. Scand J Rheumatol 1976; 5: 177
   PubMed Web of Science ®Google Scholar
• Maddison P. J., Mogavero H., Reichlin M. Patterns of clinical disease associated with antibodies to nuclear ribonucleoprotein. J Rheumatol 1978; 5: 407
   PubMedGoogle Scholar
• Ginsburg W. W., Conn D. L., Bunch T. W., McDuffie F. C. Comparison of clinical and serological markers in SLE and overlap syndrome. A review of 247 patients. J Rheumatol 1983; 10: 235
   PubMed Web of Science ®Google Scholar
• Weiss R. A., Mogavero H. S., Synkawski D. R., Provost T. T. Diagnostic test and clinical subsets in SLE: update 1983. Ann Allergy 1983; 51: 135
   PubMedGoogle Scholar
• Swaak A. J. G., Aarden L. A., Statius van Eps L. W., Feltkamp T. E. W. Anti-dsDNA and complement profiles as prognostic guides in SLE. Arthritis Rheum 1979; 22: 226
   PubMed Web of Science ®Google Scholar
• Swaak A. J. G., Bronsveld W., Douma J., Feltkamp T. E. W. Anti-dsDNA and complement profiles in SLE. Neth J Med 1981; 24: 152
   PubMedGoogle Scholar
• Smeenk R., Van der Lelij G., Swaak T., Groenwold J., Aarden L. Specificity to systemic lupus erythematosus of antibodies to dsDNA measured with the polyethylene glycol precipitation assay. Arthritis Rheum 1982; 25: 631
   PubMed Web of Science ®Google Scholar
• Swaak T., Smeenk R., Groenwold J., Aarden L. Clinical differences between SLE patients in relation to the avidity of their anti-dsDNA, Submitted for publication
   Google Scholar
• Sontheimer R. D., Gilliam J. N. DNA antibody class, subclass and complement fixation in SLE. Clin Immunol Immunopathol 1978; 10: 459
   PubMedGoogle Scholar
• Beaulieu A., Quismorio F. K., Jr., Kitridou R. G., Friou G. Complement fixing antibodies to dsDNA in SLE: a study using the immunofluorescent Crithidia luciliae method. J Rheumatol 1979; 6: 389
   PubMedGoogle Scholar
• Beaulieu A., Quismorio F., Friou G., Vayeveguta B., Mirrick G. Ig-antibodies to doublestranded DNA in SLE. Independent variation of complement fixing and total antibody content. Arthritis Rheum 1979; 22: 565
   PubMed Web of Science ®Google Scholar
• Ballou S. P., Kushner I. Immunochemical characteristics of antibodies to DNA in patients with active lupus erythematosus. Clin Exp Immunol 1979; 37: 58
   PubMedGoogle Scholar
• Herrera Esparza R., Swaak T., Aarden L., Smeenk R. Complement fixing antibodies to dsDNA detected by the IFT on Crithidia luciliae. A critical appraisal, Submitted for publication
   Google Scholar
• Beaufils M., Kouki F., Mignon F., Camus J. P., Morel-Maroger L., Richet G. Clinical significance of anti-Sm antibodies in SLE. Am J Med 1983; 74: 201
   PubMed Web of Science ®Google Scholar
• Winn D. M., Wolfe J. F., Linberg D. A., Fristoe F. M., Kingsland L., Sharp G. C. Identification of a clinical subset of SLE by antibodies to the Sm antigen. Arthritis Rheum 1979; 22: 1334
   PubMed Web of Science ®Google Scholar
• Barada F. A., Andrews B. S., Davis J. S., Taylor R. P. Antibodies to Sm in patients with SLE: correlation of Sm antibody titers with disease activity and other laboratory parameters. Arthritis Rheum 1981; 24: 1236
   PubMed Web of Science ®Google Scholar
• Munves E. F., Schur P. H. Antibodies to Sm and RNP. Prognosticators of disease involvement. Arthritis Rheum 1983; 26: 848
   PubMedGoogle Scholar
• Synkowski D. R., Reichlin M., Provost T. Serum autoantibodies in SLE and correlation with cutaneous features. J Rheumatol 1982; 9: 380
   PubMedGoogle Scholar
• Winfield J. B., Brunner C. M., Koffler D. Serologic studies in patients with SLE and nervous dysfunction. Arthritis Rheum 1978; 21: 289
   PubMed Web of Science ®Google Scholar
• Venables P. J. W., Erhardt C. C., Maini R. N. Antibodies to ENA in RA: relationship to vasculitis and circulating immune complexes. Clin Exp Immunol 1982; 39: 146
   Google Scholar
• Alexander E. L., Hirsch T. J., Amett F. C., Provost T. T., Stevens M. Ro (SS-A) and La (SS-B) antibodies in the clinical spectrum of Sjögren's syndrome. J Rheumatol 1982; 9: 239
   PubMed Web of Science ®Google Scholar
• Fritzler M., Ryan P., Kinsella T. D. Clinical features of SLE patients with anti-histone antibodies. J Rheumatol 1982; 9: 46
   PubMedGoogle Scholar
• Harbeck R. J., Bardana E. J., Kohler P. F., Carr R. I. DNA/anti-DNA complexes: their detection in systemic lupus erythematosus. J Clin Invest 1973; 52: 789
   PubMed Web of Science ®Google Scholar
• Nydegger K. E., Lambert P. H., Gerber H., Miescher P. A. Circulating immune complexes in the serum in SLE and in carriers of hepatitis B antigen. Quantitation by binding to radio-labeld Clq. J Clin Invest 1974; 54: 297
   PubMed Web of Science ®Google Scholar
• Bruneau C., Benveniste J. Circulating DNA/anti-DNA complexes in SLE. Detection and characterization by ultracentrifugation. J Clin Invest 1979; 64: 191
   PubMedGoogle Scholar
• Tron F., Letarte J., Roque-Antines Barreira M. C., Lesavre P. Specific detection of circulating DNNanti-DNA complexes in human SLE sera using murine monoclonal anti-DNA antibody. Clin Exp Immunol 1982; 49: 481
   PubMedGoogle Scholar
• Steinman Ch. R. Free DNA in serum and plasma from normal adults. J Clin Invest 1975; 56: 512
   PubMed Web of Science ®Google Scholar
• Steinman Ch. R. Circulating DNA in SLE. Association with central nervous system involvement and systemic vasculitis. Am J Med 1979; 67: 429
   PubMedGoogle Scholar
• Emlen W., Mannik M. Kinetics and mechanisms for removal of circulating single-stranded DNA in mice. J Exp Med 1978; 147: 147
   PubMedGoogle Scholar
• Emlen W., Mannik M. Effect of DNA size and strandedness on the in vivo clearance and organ localization of DNA. Clin Exp Immunol 1984; 56: 185
   PubMed Web of Science ®Google Scholar
• Faaber P., Capel P. J. A., Rijke G. P. M., Vierwinden G., v.d. Putte L. B. A., Koene R. A. P. Cross-reactivity of anti-DNA antibodies with proteoglycans. Clin Exp Immunol 1984; 55: 502
   PubMed Web of Science ®Google Scholar
• Koike T., Tomioka H., Kumagai A. Antibodies cross-reactive with DNA and cardiolipin in patients with SLE. Clin Exp Immunol 1982; 50: 298
   PubMed Web of Science ®Google Scholar
• Koike T., Sueishi M., Funaki M., Tomioka H., Yoshida S. Anti-phospholipid antibodies and biological false positive serological test for syphilis in patients with SLE. Clin Exp Immunol 1984; 56: 193
   PubMed Web of Science ®Google Scholar
• Lafer E., Rauch J., Andrzjewski C., Mudd D., Furie B., Furie B., Schwartz R. S., Stollar B. D. Polyspecific monoclonal lupus autoantibodies reactive with both polynucleotides and phospholipids. J Exp Med 1981; 153: 897
   PubMed Web of Science ®Google Scholar
• Koffler D., Agnello V., Thoburn R., Kunkel H. G. SLE: prototype of immune complex nephritis in man. J Exp Med 1971; 134: 169s
   PubMed Web of Science ®Google Scholar
• Winfield J. B., Koffler D., Kunkel H. G. Role of DNNanti-DNA complexes in the immunopathogenesis of tissue injury in SLE. Scand J Rheumatol, Suppl. 1975; 11: 59
   PubMedGoogle Scholar
• Winfield J. B., Faiferman I., Koffler D. Avidity of anti-DNA antibodies in serum and glomerular eluates from patients with SLE. Association of high avidity anti-native DNA antibody with glomerulonephritis. J Clin Invest 1977; 59: 90
   PubMed Web of Science ®Google Scholar
• Tan E. M., Fritzler M. J., McDougal S., McDuffie F. C., Nakaura R. M., Reichlin M., Reimer C. B., Sharp G. C., Schur P. M., Wilson M. R., Winchester R. J. Reference sera for ANA. I. Antibodies to native DNA, Sm, nuclear RNP and SS-B/La. Arthritis Rheum 1982; 25: 1003
   PubMedGoogle Scholar
• Lerner M. R., Steitz J. A. Antibodies to small nucler RNA's complexed with proteins are produced by patients with SLE. PNAS US 1979; 76: 5495
   PubMed Web of Science ®Google Scholar
• Wooley J. C., Zukerberg L. R., Chung S.-Y. Polypeptide components of human small nuclear ribonucleoproteins. PNAS US 1983; 80: 5208
   PubMedGoogle Scholar
• Billings P. B., Hoch S. O. Isolation of intact Sm/RNP antigens from rabbit thymus. J Immunol 1983; 131: 347
   PubMedGoogle Scholar
• Eisenberg R. A., Klapper D. G., Cohen P. L. The polypeptide structure of the Sm and RNP nuclear antigens. Molec Immunol 1983; 20: 187
   PubMedGoogle Scholar
• Guldner H. H., Lakomek H. J., Bautz F. A. Identification of human Sm and (Ul) RNP antigens by immunoblotting. J Immunol Meth 1983; 64: 45
   PubMed Web of Science ®Google Scholar
• Habets W. J., De Rooij D. J., Salden H. H., Verhagen A. P., Van Eekelen C. A., v.d. Putte L. B. A., Van Venrooij W. J. Antibodies against distinct nuclear matrix proteins are characteristic for MCTD. Clin Exp Immunol 1983; 54: 265
   PubMed Web of Science ®Google Scholar